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The pulmonary route presents several advantages in design-
ing drug delivery systems in both systemic and topical
administration. The use of particulate carriers is an attrac-
tive method for designing pulmonary drug delivery systems,
because such carriers could control drug release and selec-
tive drug targeting when the carriers reach the target site in
the lung. The prevention of local irritation, reduced drug tox-
icity, and improved drug stability are also preferable results of
utilizing such carrier systems. Among a number of particu-
late carriers, liposomes have an advantage in safety, because
they consist of phospholipids, which are bio-components.More-
over, liposomes are able to entrap both hydrophilic and
hydrophobic drugs.
In the previous study, we have reported an application of
liposomes in designing a dosage form of inhales [1,2]. In con-
sidering the actual dosage form design of liposomal suspension,
the use of nebulizers or other inhalation systems is required.
The inhalation properties of liposomal suspension are impor-
tant to complete in final liposomal inhalation.The purpose of
this study was to evaluate inhalation property and stability of
liposomes after nebulization.Three nebulizer devices, namely
air-jet, ultrasonic and passively vibrating mesh nebulizers were
used in this study. Several types of water-soluble molecules
having different molecular weights were selected as model
drugs in the formulation. The water-soluble drug loaded lipo-
somes were prepared by hydration method. Particle size of the
liposomes was controlled by the extrusion method with an ex-
truder equipped with a polycarbonate filter (100 nm). The
liposomes were aerosolized by a variety of nebulizers to
examine the optimal device for atomization of liposomal for-
mulations. Furthermore, we studied the effects of physical
properties of liposomes on inhalation properties. From the result
of inhalation properties measured by Andersen cascade im-
pactor (ACI), we found that the air-jet nebulizer is the most
efficient device in delivering the liposomal formulations to the
pulmonary parts (Fig. 1).The delivery efficiency to the lung de-
creased and the leakage of encapsulated drug increased with
the increasing liposomal size. Furthermore, the small-molecular
drug loaded liposomes tended to be leaked more from lipo-
somes during atomization thanmacromolecular drug. However,
the leakage amount of small-molecule drug depended on the
particle size of liposomes and depressed by decreasing it up
to 100 nm. From the above results, the air-jet nebulizer is con-
cluded to be the most efficient devices for the nebulization of
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liposomes and the particle size of liposomes is also the key
factor to design the liposomal inhales.
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Fig. 1 – ACI dispersion data of liposomes nebulized by air-
jet nebulizer (mean ± S.D., n = 3).
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